Recent Comments

Comment RSS

Paralysis News and Research RSS Feed - Paralysis News and Research

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.

Experimental drug to restore function of nerves damaged in spinal cord injuries shows promise

20. November 2009 00:04
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , ,

New photocontrolled molecular switch regulates paralysis in living organisms

19. November 2009 06:20
In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off "switch" that paralyzes animals when exposed to a beam of ultraviolet light. The animals stay paralyzed even when the light is turned off. When exposed to ordinary light, the animals become unparalyzed and wake up. [More]

Posted in: Medical Science News

Tags: , , ,

Study examines how dietary restriction and high-caloric diet influence biochemical responses

19. November 2009 03:26
Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease? [More]

Neuralstem provides financial and business updates for third-quarter 2009

17. November 2009 08:30
Neuralstem, Inc. today provided a financial and business update for the third quarter ended September 30, 2009. [More]

CRPS patients fare better with aggressive physiotherapy treatment, says new study

13. November 2009 03:38
The saying "more pain, more gain" may be true for those already in terrible pain due to a chronic and debilitating condition, contrary to received wisdom. For those with Type I Complex Regional Pain Syndrome (CRPS), working through the pain of an aggressive physiotherapy program often leads to far better results than a more cautious pain-free approach. [More]

Posted in: Medical Condition News

Tags: , , , ,

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

12. November 2009 03:47
Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function. [More]

NMO patients are misdiagnosed with Multiple Sclerosis, says Mayo Clinic neurologist

12. November 2009 03:18
Thousands of Neuromyelitis Optica (NMO) patients are potentially being misdiagnosed with Multiple Sclerosis (MS), according to Mayo Clinic Neurologist Sean Pittock, M.D., largely due to lack of awareness of NMO within the medical community. [More]

AMT's gene therapy successful in treating Duchenne muscular dystrophy

11. November 2009 03:27
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles. [More]

FDA approved stem cell therapy restores limb function in rats with neck spinal cord injuries

10. November 2009 01:02
The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage. [More]

New approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres discovered

9. November 2009 00:16
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident. [More]

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

6. November 2009 02:10
Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility. [More]

Arrowhead Research updates its shareholders

3. November 2009 08:13
Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders. [More]

Posted in: Business / Finance

Tags: , , , , , , , , , ,

CNS cancer survivors have greater neurocognitive dysfunction than survivors of other types of cancer

2. November 2009 01:27
Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems. [More]

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

29. October 2009 04:20
The Salk Institute has been awarded a $10.8 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) - or Lou Gehrig's Disease. [More]

Moores UCSD Cancer Center awarded $20 million for cancer research

28. October 2009 16:30
Researchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.